These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1547059)

  • 21. A comparison of edrophonium and neostigmine for the antagonism of atracurium-induced neuromuscular block.
    Lavery GG; Mirakhur RK; Gibson FM
    Anesth Analg; 1985 Sep; 64(9):867-70. PubMed ID: 3161421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1986 Nov; 58(11):1285-9. PubMed ID: 2877681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of edrophonium and neostigmine when antagonizing d-tubocurarine neuromuscular blockade in man.
    Morris RB; Cronnelly R; Miller RD; Stanski DR; Fahey MR
    Anesthesiology; 1981 May; 54(5):399-401. PubMed ID: 7224209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonism of vecuronium-induced neuromuscular blockade with edrophonium or neostigmine.
    Mirakhur RK; Gibson FM; Lavery GG
    Br J Anaesth; 1987 Apr; 59(4):473-7. PubMed ID: 2882768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different properties of the bradycardia produced by neostigmine and edrophonium in the cat.
    Backman SB; Stein RD; Blank DW; Collier B; Polosa C
    Can J Anaesth; 1996 Jul; 43(7):731-40. PubMed ID: 8807181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonism of atracurium-induced neuromuscular blockade by neostigmine or edrophonium.
    Astley BA; Hughes R; Payne JP
    Br J Anaesth; 1986 Nov; 58(11):1290-5. PubMed ID: 3778793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The reversal of profound mivacurium-induced neuromuscular blockade.
    Kao YJ; Le ND
    Can J Anaesth; 1996 Nov; 43(11):1128-33. PubMed ID: 8922768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
    Bartunek A; Gilly H; Huemer G; Yildiz S; Schramm W; Lackner FX; Foldes FF
    Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonism of vecuronium and atracurium: comparison of neostigmine and edrophonium administered at 5% twitch height recovery.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1987 Apr; 59(4):478-81. PubMed ID: 2882769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neostigmine and edrophonium for reversal of pipecuronium neuromuscular blockade.
    Abdulatif M; Naguib M
    Can J Anaesth; 1991 Mar; 38(2):159-63. PubMed ID: 1850665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
    Fleming NW; Macres S; Antognini JF; Vengco J
    Br J Anaesth; 1996 Oct; 77(4):492-5. PubMed ID: 8942334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of neostigmine or edrophonium on force of contraction when administered at a train-of-four ratio of 0.9 in anesthetized dogs.
    Romano M; Martin-Flores M; Sakai DM; Tseng CT; Campoy L; Gleed RD
    Vet Anaesth Analg; 2017 Nov; 44(6):1313-1320. PubMed ID: 29066245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonism of vecuronium paralysis: comparison between edrophonium and neostigmine.
    Dernovoi BS
    Acta Anaesthesiol Belg; 1991; 42(1):65-71. PubMed ID: 1676233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neostigmine, pyridostigmine and edrophonium as antagonists of deep pancuronium blockade.
    Donati F; Lahoud J; McCready D; Bevan DR
    Can J Anaesth; 1987 Nov; 34(6):589-93. PubMed ID: 3677283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonism of intense atracurium-induced neuromuscular block in children.
    Gwinnutt CL; Walker RW; Meakin G
    Br J Anaesth; 1991 Jul; 67(1):13-6. PubMed ID: 1859751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recovery characteristics following antagonism of atracurium with neostigmine or edrophonium.
    Jones RM; Pearce AC; Williams JP
    Br J Anaesth; 1984 May; 56(5):453-7. PubMed ID: 6326785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Verapamil potentiation of neuromuscular blockade: failure of reversal with neostigmine but prompt reversal with edrophonium.
    Jones RM; Cashman JN; Casson WR; Broadbent MP
    Anesth Analg; 1985 Oct; 64(10):1021-5. PubMed ID: 4041146
    [No Abstract]   [Full Text] [Related]  

  • 39. Antagonism of alcuronium with edrophonium or neostigmine.
    Harper NJ; Bradshaw EG; Healy TE
    Br J Anaesth; 1984 Oct; 56(10):1089-94. PubMed ID: 6089857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade.
    Donati F; Smith CE; Bevan DR
    Anesth Analg; 1989 Jan; 68(1):13-9. PubMed ID: 2910133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.